A detailed history of Virtus ETF Advisers LLC transactions in Amgen Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 1,103 shares of AMGN stock, worth $323,774. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,103
Previous 1,103 -0.0%
Holding current value
$323,774
Previous $344,000 3.2%
% of portfolio
0.17%
Previous 0.18%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $73,044 - $88,768
-278 Reduced 20.13%
1,103 $344,000
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $53,774 - $64,912
200 Added 16.93%
1,381 $392,000
Q4 2023

Feb 15, 2024

SELL
$255.7 - $288.46 $50,628 - $57,115
-198 Reduced 14.36%
1,181 $340,000
Q3 2023

Nov 07, 2023

SELL
$218.65 - $271.46 $36,514 - $45,333
-167 Reduced 10.8%
1,379 $370,000
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $85,279 - $100,841
398 Added 34.67%
1,546 $343,000
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $7,225 - $8,806
32 Added 2.87%
1,148 $277,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $26,338 - $33,466
115 Added 11.49%
1,116 $293,000
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $3,591 - $4,050
16 Added 1.62%
1,001 $226,000
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $174,186 - $193,838
-755 Reduced 43.39%
985 $240,000
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $30,030 - $34,367
-151 Reduced 7.99%
1,740 $391,000
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $37,996 - $44,517
-179 Reduced 8.65%
1,891 $402,000
Q2 2021

Aug 10, 2021

SELL
$233.58 - $259.14 $158,834 - $176,215
-680 Reduced 24.73%
2,070 $505,000
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $21,747 - $25,342
98 Added 3.7%
2,750 $684,000
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $6,707 - $7,987
-31 Reduced 1.16%
2,652 $610,000
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $53,265 - $59,235
227 Added 9.24%
2,683 $682,000
Q2 2020

Aug 05, 2020

SELL
$197.81 - $242.74 $6,527 - $8,010
-33 Reduced 1.33%
2,456 $579,000
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $38,270 - $50,757
-210 Reduced 7.78%
2,489 $505,000
Q4 2019

Feb 13, 2020

SELL
$189.21 - $243.2 $234,620 - $301,568
-1,240 Reduced 31.48%
2,699 $651,000
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $114,564 - $137,271
-658 Reduced 14.31%
3,939 $762,000
Q2 2019

Aug 13, 2019

BUY
$166.7 - $195.41 $766,319 - $898,299
4,597 New
4,597 $847,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.